Vimarsana
Biggest News Aggregation in the World

Page 3 - Complete Connected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Complete Connected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Complete Connected Today - Breaking & Trending Today

Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Director/PDMR Dealings - Vimarsana News

Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Director/PDMR Dealings

Investegate announcements from Mercia Asset Mgt PLC, Director/PDMR Dealings

Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Further direct investment into Intechnica Group - Vimarsana News

Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Further direct investment into Intechnica Group

Investegate announcements from Mercia Asset Mgt PLC, Further direct investment into Intechnica Group

Broker Insights' US expansion after £6m fundraise - Vimarsana News

Broker Insights' US expansion after £6m fundraise

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com
Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Mercia accredited to deliver Recovery Loan Scheme - Vimarsana News

Investegate |Mercia Asset Mgt PLC Announcements | Mercia Asset Mgt PLC: Mercia accredited to deliver Recovery Loan Scheme

Investegate announcements from Mercia Asset Mgt PLC, Mercia accredited to deliver Recovery Loan Scheme

Invizius Announces Successful Series A Financing to Develop Anti-Inflammatory Treatment for Haemodialysis - Vimarsana News

Invizius Announces Successful Series A Financing to Develop Anti-Inflammatory Treatment for Haemodialysis

Share this article Share this article MOTHERWELL, Scotland, May 6, 2021 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted innate immune responses, today announces that it has closed Series A financing of £5.3 million. The financing was led by existing investors Mercia, Downing Ventures, Old College Capital, Scottish Enterprise, Solvay Ventures and new investors Calculus Capital and experienced life science entrepreneur and investor, Dr Jonathan Milner. Although already over-subscribed, the company's Series A remains open to ot...